Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aragon Pharmaceuticals describes new androgen receptor ligands

Sep. 22, 2011

New histone deacetylase inhibitors prepared by Millennium Pharmaceuticals

Sep. 22, 2011

Novel anticancer furoxan derivatives synthesized

Sep. 22, 2011

ARIAD Pharmaceuticals advances phase I/II AP-26113 trial

Sep. 22, 2011

University of Pittsburgh presents new anticancer agents

Sep. 22, 2011

Results presented from ENCORE 301 study of exemestane plus entinostat in advanced breast cancer

Sep. 22, 2011

Bionomics provides update on BNC-105 study in metastatic renal cell carcinoma

Sep. 21, 2011

Progen to close phase Ia study of PG-545

Sep. 21, 2011

Niiki Pharma reports promising interim phase I data on NKP-1339

Sep. 21, 2011

First part of phase I SPI-1620 trial provides encouraging data

Sep. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...